secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0000950170-25-082005
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics resolves Nasdaq compliance, closes $5M offering, earns $7M license fee from WY Biotech
--------------------------------------------------------------------------------

- Nasdaq confirms compliance with bid price and MVPHS rules; company believes full compliance for Capital Market listing.
- Closed $5M follow-on offering (671,140 units at $7.45/unit) and reduced existing warrant exercise price to $7.45.
- WY Biotech license fully binding; HCW Biologics earns $7M upfront fee recognized in Q2 2025.
- Converted $6.6M secured notes into common stock, warrants, and Wugen shares; reduced debt and improved equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025082005/0000950170-25-082005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025082005/hcwb-20250605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-082005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer